Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enanta Pharmaceutica (ENTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Enanta Pharmaceu Falls 2.58% on Heavy Volume: Watch For Potential Rebound

Enanta Pharmaceu (NASDAQ:ENTA) traded in a range yesterday that spanned from a low of $89.76 to a high of $92.17. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of...

ENTA : 85.80 (+0.78%)
Enanta Pharmaceuticals Presents New Preclinical Data on Compounds Targeting Hepatitis B Virus and Non-Alcoholic Steatohepatitis at The International Liver Congress(TM) 2019

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced...

ENTA : 85.80 (+0.78%)
AbbVie's MAVIRET(TM) now reimbursed in Quebec

AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company announced today that MAVIRET(TM) (glecaprevir/pibrentasvir tablets) is now listed as a medication covered under Quebec's...

ENTA : 85.80 (+0.78%)
ABBV : 77.57 (-0.53%)
Market Trends Toward New Normal in Tesla, Zuora, SunOpta, Internap, Enanta Pharmaceuticals, and Hilton Grand Vacations -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tesla, Inc. (NASDAQ:TSLA),...

TSLA : 273.26 (+0.75%)
STKL : 3.30 (+1.54%)
ZUO : 19.22 (-1.69%)
INAP : 4.38 (-5.19%)
ENTA : 85.80 (+0.78%)
HGV : 32.67 (-0.31%)
Enanta Pharmaceu Shares Down 2.8% Since SmarTrend's Sell Call (ENTA)

SmarTrend identified a Downtrend for Enanta Pharmaceu (NASDAQ:ENTA) on March 25th, 2019 at $95.15. In approximately 2 weeks, Enanta Pharmaceu has returned 2.84% as of today's recent price of $92.45.

ENTA : 85.80 (+0.78%)
AbbVie Announces New Formulary Listings for its Hepatitis C Treatment MAVIRET(TM)

AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company, announced that MAVIRETTM (glecaprevir/pibrentasvir tablets) is now reimbursed in Alberta, Saskatchewan and the Non-Insured...

ENTA : 85.80 (+0.78%)
ABBV : 77.57 (-0.53%)
The Zacks Analyst Blog Highlights: Celgene, Puma, Exelixis, Enanta and Sage

The Zacks Analyst Blog Highlights: Celgene, Puma, Exelixis, Enanta and Sage

CELG : 93.76 (-0.57%)
ENTA : 85.80 (+0.78%)
PBYI : 32.89 (+0.09%)
EXEL : 20.90 (-2.15%)
SAGE : 164.73 (+2.02%)
Biotech Stocks Outperform During Inversions: 5 Must Watch

An inverted yield curve signals a recession but it is often bullish for biotech stocks.

CELG : 93.76 (-0.57%)
ENTA : 85.80 (+0.78%)
PBYI : 32.89 (+0.09%)
EXEL : 20.90 (-2.15%)
SAGE : 164.73 (+2.02%)
PFE : 39.38 (-1.25%)
BMY : 45.52 (-0.61%)
Enanta Pharmaceuticals Announces Data Presentations at The International Liver Congress(TM) 2019

--FXR agonist EDP-305 targeting NASH

ENTA : 85.80 (+0.78%)
British Columbia PharmaCare Lists AbbVie's Hepatitis C Treatment MAVIRET(TM) on its Formulary

AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company, announced that MAVIRETTM (glecaprevir/pibrentasvir tablets) is now reimbursed in British Columbia. MAVIRET is a...

ENTA : 85.80 (+0.78%)
ABBV : 77.57 (-0.53%)
Look for Shares of Enanta Pharmaceu to Potentially Rebound after Yesterday's 7.42% Sell Off

Enanta Pharmaceu (NASDAQ:ENTA) traded in a range yesterday that spanned from a low of $96.07 to a high of $98.92. Yesterday, the shares fell 7.4%, which took the trading range below the 3-day low of...

ENTA : 85.80 (+0.78%)
Enanta Pharmaceu Up 37.9% Since SmarTrend Uptrend Call (ENTA)

SmarTrend identified an Uptrend for Enanta Pharmaceu (NASDAQ:ENTA) on January 7th, 2019 at $74.33. In approximately 2 months, Enanta Pharmaceu has returned 37.87% as of today's recent price of $102.48....

ENTA : 85.80 (+0.78%)
Enanta Pharmaceuticals Completes Enrollment in Two Ongoing Phase 2 Studies

--ARGON-1 Study in Non-alcoholic Steatohepatitis (NASH) with EDP-305

ENTA : 85.80 (+0.78%)
Enanta Pharmaceu Rises 1.43% on Heavy Volume: Watch For Potential Pullback

Enanta Pharmaceu (NASDAQ:ENTA) traded in a range yesterday that spanned from a low of $103.21 to a high of $103.54. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high...

ENTA : 85.80 (+0.78%)
Enanta Pharmaceu Up 36.6% Since SmarTrend Uptrend Call (ENTA)

SmarTrend identified an Uptrend for Enanta Pharmaceu (NASDAQ:ENTA) on January 7th, 2019 at $74.33. In approximately 2 months, Enanta Pharmaceu has returned 36.55% as of today's recent price of $101.50....

ENTA : 85.80 (+0.78%)
Uptrend Call Working As Enanta Pharmaceu Stock Rises 37.4% (ENTA)

SmarTrend identified an Uptrend for Enanta Pharmaceu (NASDAQ:ENTA) on January 7th, 2019 at $74.33. In approximately 2 months, Enanta Pharmaceu has returned 37.41% as of today's recent price of $102.14....

ENTA : 85.80 (+0.78%)
AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for its hepatitis C treatment MAVIRET(TM)

AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company, announced an agreement was reached with the pan-Canadian Pharmaceutical Alliance (pCPA) regarding MAVIRETTM (glecaprevir/pibrentasvir...

ENTA : 85.80 (+0.78%)
ABBV : 77.57 (-0.53%)
36.0% Return Seen to Date on SmarTrend Enanta Pharmaceu Call (ENTA)

SmarTrend identified an Uptrend for Enanta Pharmaceu (NASDAQ:ENTA) on January 7th, 2019 at $74.33. In approximately 1 month, Enanta Pharmaceu has returned 36.00% as of today's recent price of $101.09....

ENTA : 85.80 (+0.78%)
Factors of Influence in 2019, Key Indicators and Opportunity within BCE, Nektar Therapeutics, Hormel Foods, Enanta Pharmaceuticals, MongoDB, and Regal Beloit -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of BCE, Inc. (NYSE:BCE), Nektar...

RBC : 84.69 (+0.26%)
HRL : 40.39 (-0.81%)
BCE : 45.44 (+0.22%)
ENTA : 85.80 (+0.78%)
MDB : 125.38 (-5.15%)
NKTR : 31.68 (+1.57%)
Noteworthy Wednesday Option Activity: ENTA, INSM, PPC

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Enanta Pharmaceuticals Inc , where a total volume of 1,646 contracts has been traded...

ENTA : 85.80 (+0.78%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ +0.08
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar